Back to search
Essential Tremor (ET)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Essential Tremor (ET) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Essential Tremor (ET) trials you may qualify forThe purpose of this study is to collect electrophysiological data related to functional brain network changes in patients undergoing deep brain stimulation for…
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used acco…
The purpose of this research is to learn more about how the brain works in people with essential tremor, and how it changes after treatment with High-Intensity…
Essential Tremor (ET) is prevalent, affecting approximately 3% of the adult population. Involuntary shaking of the hands during action is a prominent feature, i…
Deep brain stimulation (DBS) targeting the Vim thalamus (ventralis intermedius nucleus) is an FDA-approved neuromodulation therapy for treating postural and act…
This will be a single center (OHSU) proof of concept trial to demonstrate that directional deep brain stimulation (DBS) creates a larger therapeutic window for…
Deep brain stimulation (DBS) of both ventral intermediate nucleus (VIM) and the posterior subthalamic area (PSA) has shown to be an effective treatment for esse…
The purpose of this study is to measure the effects of non-regular temporal patterns of deep brain stimulation (DBS) on motor symptoms and neural activity in pe…
Experiment 1: Modulation of Physiological Tremor in Healthy Volunteers Thirty healthy volunteers will undergo TUS targeting the dentate nucleus in a randomized,…